M. Hensel

3.1k total citations
25 papers, 564 citations indexed

About

M. Hensel is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, M. Hensel has authored 25 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Oncology and 10 papers in Genetics. Recurrent topics in M. Hensel's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (4 papers). M. Hensel is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Viral-associated cancers and disorders (4 papers). M. Hensel collaborates with scholars based in Germany, Austria and Estonia. M. Hensel's co-authors include Anthony D. Ho, Andreas Schneeweiß, Gerlinde Egerer, H. Goldschmidt, Christiane Pott, Michael Kneba, Johannes Schetelig, Martin Bornhäuser, J. Beyer and K. Höffken and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

M. Hensel

25 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Hensel Germany	10	257	253	241	216	110	25	564
Peter Joosten Netherlands	10	155 0.6×	110 0.4×	212 0.9×	227 1.1×	180 1.6×	18	527
Eva Hoke United States	14	158 0.6×	157 0.6×	390 1.6×	231 1.1×	67 0.6×	22	662
Aline Schmidt France	11	76 0.3×	153 0.6×	320 1.3×	139 0.6×	101 0.9×	44	526
Shankara Paneesha United Kingdom	11	154 0.6×	154 0.6×	134 0.6×	186 0.9×	109 1.0×	39	434
Hagop M. Kantarjian United States	11	122 0.5×	256 1.0×	437 1.8×	157 0.7×	56 0.5×	17	650
Beata Stella‐Hołowiecka Poland	9	134 0.5×	195 0.8×	213 0.9×	69 0.3×	97 0.9×	31	440
Edward Peres United States	10	78 0.3×	159 0.6×	337 1.4×	127 0.6×	165 1.5×	39	554
Bhausaheb Bagal India	10	101 0.4×	107 0.4×	142 0.6×	146 0.7×	92 0.8×	104	413
Bungo Saito Japan	14	102 0.4×	79 0.3×	205 0.9×	164 0.8×	104 0.9×	47	485
Marc Maynadié France	13	153 0.6×	235 0.9×	161 0.7×	114 0.5×	110 1.0×	21	450

Countries citing papers authored by M. Hensel

Since Specialization

Citations

This map shows the geographic impact of M. Hensel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hensel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hensel more than expected).

Fields of papers citing papers by M. Hensel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hensel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hensel. The network helps show where M. Hensel may publish in the future.

Co-authorship network of co-authors of M. Hensel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hensel. A scholar is included among the top collaborators of M. Hensel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hensel. M. Hensel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ebner, Florian, et al.. (2024). Endometriosis Coinciding with Uterus Didelphys and Renal Agenesis: A Literature Review. Journal of Clinical Medicine. 13(24). 7530–7530. 1 indexed citations

2.

Hoffmann, Christian, Marcus Hentrich, Daniel Gillor, et al.. (2014). Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study. HIV Medicine. 16(4). 261–264. 20 indexed citations

3.

Hensel, M., Christoph Plöger, Stefan Fuxius, et al.. (2012). Excellent long-term survival of 170 patients with Waldenström’s macroglobulinemia treated in private oncology practices and a university hospital. Annals of Hematology. 91(12). 1923–1928. 8 indexed citations

4.

Kornacker, Martin, Christiane Pott, Sascha Dietrich, et al.. (2009). Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Annals of Oncology. 20(4). 722–728. 44 indexed citations

5.

Rieger, Michael A., et al.. (2007). Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome. Haematologica. 92(1). 42–49. 53 indexed citations

6.

Stilgenbauer, S., Alexander Kröber, Dirk Winkler, et al.. (2005). Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG). mediaTUM (Technical University of Munich). 18 indexed citations

7.

Schlenk, Richard F., Ulrich Germing, Frank Hartmann, et al.. (2005). High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia. 19(6). 978–983. 30 indexed citations

8.

Schneeweiß, Andreas, Ingo Diel, M. Hensel, et al.. (2004). Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy. Annals of Oncology. 15(11). 1627–1632. 1 indexed citations

9.

Hensel, M., Fatime Krasniqi, Matthias Villalobos, Martin Kornacker, & Anthony D. Ho. (2004). Pentostatin, cyclophosphamide and rituximab is an active regimen with low toxicity for previously treated patients with B-cell chronic lymphocytic leukemia and Waldenström's macroglobulinemia. Journal of Clinical Oncology. 22(14_suppl). 6557–6557. 1 indexed citations

10.

Hensel, M., Fatime Krasniqi, Matthias Villalobos, Martin Kornacker, & Anthony D. Ho. (2004). Pentostatin, cyclophosphamide and rituximab is an active regimen with low toxicity for previously treated patients with B-cell chronic lymphocytic leukemia and Waldenström's macroglobulinemia. Journal of Clinical Oncology. 22(14_suppl). 6557–6557. 1 indexed citations

11.

Schlenk, Richard F., Axel Benner, Frank Hartmann, et al.. (2003). Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial. Leukemia. 17(8). 1521–1528. 87 indexed citations

12.

Schetelig, Johannes, Christian Thiede, Martin Bornhäuser, et al.. (2003). Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group. Journal of Clinical Oncology. 21(14). 2747–2753. 169 indexed citations

13.

Hensel, M., et al.. (2002). Disease Activity and Pretreatment, but Not Hypogammaglobulinemia, Are Risk Factors for Infectious Complications in Patients with Chronic Lymphocytic Leukemia. Blood. 100(11). 496816. 1 indexed citations

14.

Schneeweiß, Andreas, M. Hensel, Hans‐Peter Sinn, et al.. (2002). Characteristics associated withlong-term progression-free survival following high-dose chemotherapyin metastatic breast cancer and influence of chemotherapy dose. Annals of Oncology. 13(5). 679–688. 8 indexed citations

15.

Hensel, M., Gerlinde Egerer, Andreas Schneeweiß, H. Goldschmidt, & Anthony D. Ho. (2002). Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation. Annals of Oncology. 13(2). 209–217. 70 indexed citations

16.

Egerer, Gerlinde, Hartmut Goldschmidt, M. Hensel, et al.. (2002). Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation. Bone Marrow Transplantation. 30(7). 427–431. 12 indexed citations

17.

Schlenk, R., Frank Hartmann, M. Hensel, et al.. (2002). Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia. Leukemia. 16(4). 581–586. 15 indexed citations

18.

Schulz, Hermann, Saskia K. Klein, U. Rehwald, et al.. (2002). Phase II Study of Rituximab in Combination With Fludarabine in Patients With Chronic Lymphocytic Leukemia. 6 indexed citations

19.

Schetelig, Johannes, Christian Thiede, Martin Bornhäuser, et al.. (2002). Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.. PubMed. 81 Suppl 2. S47–8. 7 indexed citations

20.

Schneeweiß, Andreas, M. Hensel, R. Goerner, et al.. (2001). Comparison of Double and Triple High‐Dose Chemotherapy with Autologous Blood Stem Cell Transplantation in Patients with Metastatic Breast Cancer. Stem Cells. 19(2). 151–160. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact